![]() | |
Names | |
---|---|
IUPAC name
2-(4-Cyclohexyl-1-naphthyl)propanoic acid
| |
Other names
Quadrisol
| |
Identifiers | |
3D model (JSmol)
|
|
ChEBI | |
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.068.339 ![]() |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C19H22O2 | |
Molar mass | 282.383 g·mol−1 |
Pharmacology | |
QM01AE90 (WHO) | |
Legal status | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Vedaprofen is a nonsteroidal anti-inflammatory drug (NSAID) used in veterinary medicine for the treatment of pain and inflammation due to musculoskeletal disorders in dogs and horses and for the treatment of pain due to horse colic.[4] It is a member of the profen drug class.
Medical uses
[edit]Vedaprofen is indicated for the reduction of inflammation and relief of pain associated with musculo-skeletal disorders and soft tissue lesions (traumatic injuries and surgical trauma).[1][2]
Synthesis
[edit]Vedaprofen can be synthesized beginning with 1-cyclohexylnaphthylene (left).[5][6] Chloromethylation followed by functional group interconversion provides the ester (center right). Alkylation with methyl iodide then gives vedaprofen (right).

Soceity and culture
[edit]Legal status
[edit]Vedaprofen was approved for veterinary use in the European Union in April 1997.[1][2]
References
[edit]- ^ a b c "Quadrisol EPAR". European Medicines Agency (EMA). 4 December 1997. Retrieved 26 December 2024.
- ^ a b c "Vedaprofen PI". Union Register of medicinal products. 5 December 1997. Retrieved 26 December 2024.
- ^ "Quadrisol 100 mg/ml". European Medicines Agency (EMA). 3 December 1997. Retrieved 26 December 2024.
- ^ "Specific Nonsteroidal Anti-inflammatory Drugs". Merck Veterinary Manual. Merck Sharp & Dohme Corp.
- ^ BE 870553
- ^ U.S. patent 4,218,473
pyrazolones / pyrazolidines | |
---|---|
salicylates | |
acetic acid derivatives and related substances | |
oxicams | |
propionic acid derivatives (profens) |
|
n-arylanthranilic acids (fenamates) | |
COX-2 inhibitors (coxibs) | |
other | |
NSAID combinations | |
Key: underline indicates initially developed first-in-class compound of specific group; #WHO-Essential Medicines; †withdrawn drugs; ‡veterinary use. | |